Why Aetna is still a safe investment bet; Some insurers skeptical about covering addiction treatment implant

News From Around the Web

> Even amid concerns over its pending merger with Humana, Aetna remains a safe choice for investors because it has shown the capacity to use data from its millions of healthcare customers to target new markets, according to The Street. Article

> Though Blue Cross of Massachusetts will cover a newly approved implant that treats opioid addiction, other insurers aren't sure the $4,950 price tag is worth it, Boston-based news station wbur reports on its CommonHealth blog. Article

> Prominent Republican members of the House have sent a letter to the Department of Health and Human Services, calling on the agency to comply with subpoenas for documents related to spending on the Affordable Care Act's Basic Health Program. Letter (.pdf)

AntiFraud News

> Experts say individual accountability outlined in the Yates memo, along with the potential for more whistleblower claims, will drive healthcare fraud enforcement in the coming years, according to the Dallas Business Journal. Article

> The federal government saved more than $1 billion over the last two years through its Fraud Prevention System, bringing the total savings to $1.5 billion since the program was launched in 2011, according to a Centers for Medicare and Medicaid Services blog post. Article

And Finally… Like us, or else. Article

Suggested Articles

Rebates for Part D drugs grew from 2011 to 2015 but not enough to offset price spikes, a study found.

Medicare Advantage plans still have time to meet their year-end goals.

A recent digital health conference highlighted the ongoing obstacles to using next-generation technology to impact health outcomes.